Skip to main content
. 2020 Apr 23;28(9):1265–1273. doi: 10.1038/s41431-020-0626-8

Table 2.

(A) The number and prevalence of BP1–BP2 deletions in non-syndromic CVM cases compared with controls in UK Biobank. (B) The number and prevalence of BP1–BP2 deletions in neuropsychiatric cases compared to controls in UK Biobank.

BP1–BP2 del No BP1–BP2 del Prevalence
A
Non-CVM controls 1769 470,611 0.38%
All non-syndromic CVM samples 18 2774 0.64%
B
Non-neuropsychiatric controls 1808 481,522 0.37%
Neuropsychiatric cases 24 3480 0.68%